PetVivo Reports Fiscal Q3 2025 Results
February 14, 2025 15:10 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, Feb. 14, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW), a leading biomedical company delivering innovative therapeutics and medical devices for...
PetVivo Signs Exclusive Sales and Marketing Agreement with VetStem for PrecisePRP® Canine and Equine Products
February 14, 2025 08:00 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, Feb. 14, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW), a leader in innovative veterinary medical solutions, has entered into an Exclusive License...
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE THIRD QUARTER ENDED DECEMBER 31, 2024
February 11, 2025 10:15 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, Feb. 11, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV and OTCPINK: PETVW), an emerging biomedical device company focused on the commercialization of innovative...
PetVivo Engages Former Dechra North American President, Mike Eldred as Commercial and Operations Advisor
January 27, 2025 09:29 ET
|
PetVivo Holdings, Inc.
PetVivo Board Appoints Eldred as Executive Director to Lead Company Product Commercialization and Operations MINNEAPOLIS, MN, Jan. 27, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV,...
PetVivo to Exhibit Spryng with OsteoCushion™ Technology at the Veterinary Meeting and Expo Conference in Orlando, Florida on January 25-29, 2025
January 14, 2025 09:29 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, Jan. 14, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV, PETVW), a leading provider of medical devices and biomedical therapeutics for equines and companion animals...
PETVIVO HOLDING, INC. ANNOUNCES PARTNERSHIP ENGAGEMENTS WITH VEDCO, INC. AND CLIPPER DISTRIBUTING, LLC
January 10, 2025 09:45 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, Jan. 10, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV & PETVW) ("PetVivo"), a pioneering biomedical technology company focused on adapting human biotech, medical...
MYOS Corp. Encourages Partnering with Pets for Muscle Health and Longevity
January 08, 2025 10:23 ET
|
MYOS PET
Fortetropin, a patented, natural bioactive compound found in all MYOS muscle supplements is clinically shown to support muscle health in dogs and cats.
PETVIVO HOLDINGS, INC. TO HOST SHAREHOLDERS UPDATE MEETING ON JANUARY 8, 2025
December 30, 2024 10:23 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, Dec. 30, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical...
PetVivo to Exhibit Spryng with OsteoCushion™ Technology at the American Association of Equine Practitioners Convention on December 8-10, 2024
November 26, 2024 15:00 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, Nov. 26, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV, PETVW), a leading provider of medical devices and biomedical therapeutics for equines and companion animals,...
PetVivo Reports Fiscal Q2 2025 Results
November 14, 2024 16:00 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, Nov. 14, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV, PETVW), a leading biomedical company delivering innovative therapeutic medical devices for equines and...